All Specialties CardiologyNephrologyEndocrinologyPrimary CarePrescribing Information Previous Next MAKE PROTECTION YOUR SUPERPOWER Protect your patients who have cardio, renal, and metabolic conditions. Shorts See all > Read more Christiane Angermann (Germany) | Ricardo Carvalho (Portugal) Clinical relationship between the heart and the kidneys Watch now Opens in new tab Read more Christiane Angermann (Germany) | Ricardo Carvalho (Portugal) Why is empagliflozin now a preferred heart failure treatment, coming from a history of diabetes? Watch now Opens in new tab Read more Christiane Angermann (Germany) | Ricardo Carvalho (Portugal) How has recent evidence and the ESC 2023 guidelines changed management of heart failure? Watch now Opens in new tab Upcoming Events See all > Read more PRIME SUMMIT 2 From screening to protection: Advancing cardiorenal metabolic care with SGLT2 inhibitors Read more Opens in new tab Past Events See all > Read more Christiane Angermann (Germany) | Ricardo Carvalho (Portugal) The heart failure patient through a holistic lens (Full) Watch now Opens in new tab Read more Christiane Angermann (Germany) | Ricardo Carvalho (Portugal) The heart failure patient through a holistic lens (Summary) Watch now Opens in new tab Read more Subodh Verma (Canada) | Soo Yong Lee (Korea) SGLT2 inhibitor: Essential foundation for heart failure treatment (Summary 1) Watch now Opens in new tab Resources See all > Read more ESC 2023 focused update Read more Opens in new tab Read more H2FPEF score to guide HFpEF diagnosis Read more Opens in new tab Patient Materials See all > Read more PDF Monitoring your heart failure symptoms Read more Opens in new tab
Read more Christiane Angermann (Germany) | Ricardo Carvalho (Portugal) Clinical relationship between the heart and the kidneys Watch now Opens in new tab
Read more Christiane Angermann (Germany) | Ricardo Carvalho (Portugal) Why is empagliflozin now a preferred heart failure treatment, coming from a history of diabetes? Watch now Opens in new tab
Read more Christiane Angermann (Germany) | Ricardo Carvalho (Portugal) How has recent evidence and the ESC 2023 guidelines changed management of heart failure? Watch now Opens in new tab
Read more PRIME SUMMIT 2 From screening to protection: Advancing cardiorenal metabolic care with SGLT2 inhibitors Read more Opens in new tab
Read more Christiane Angermann (Germany) | Ricardo Carvalho (Portugal) The heart failure patient through a holistic lens (Full) Watch now Opens in new tab
Read more Christiane Angermann (Germany) | Ricardo Carvalho (Portugal) The heart failure patient through a holistic lens (Summary) Watch now Opens in new tab
Read more Subodh Verma (Canada) | Soo Yong Lee (Korea) SGLT2 inhibitor: Essential foundation for heart failure treatment (Summary 1) Watch now Opens in new tab